edaravone has been researched along with Hyperplasia in 1 studies
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radhakrishnan, G | 1 |
| Suzuki, R | 1 |
| Maeda, H | 1 |
| Yamamoto, M | 1 |
| Hirose, N | 1 |
| Gopalrao, RK | 1 |
| Lee, GH | 1 |
| Hayashi, Y | 1 |
| Rao, P | 1 |
| Sasaguri, S | 1 |
1 other study available for edaravone and Hyperplasia
| Article | Year |
|---|---|
Inhibition of neointimal hyperplasia development by MCI-186 is correlated with downregulation of nuclear factor-kappaB pathway.
Topics: Angioplasty, Balloon; Animals; Antioxidants; Antipyrine; Carotid Artery Diseases; Carotid Artery Inj | 2008 |